A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome

NCT00251511 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
60
Enrollment
OTHER
Sponsor class

Stopped Sponsor terminated trial

Conditions

Interventions

Sponsor

Veeda Oncology

Collaborators